In The Press

NeuraMetrix in the Press

March 29, 2024

NeuraMetrix: Transforming Neurological Diagnostics with Innovative Digital Biomarker

HITLAB

In an innovative approach, NeuraMetrix has identified a novel digital biomarker for neurological disorders: typing cadence, the distinctive rhythm individuals employ when typing on a keyboard.

Read More

June 29, 2021

Bright Ideas in Neurological Devices

Medical Device and Diagnostics Industry (MDDI)

A look at the latest medical device innovations for neurological disorders and conditions including NeuraMetrix’s digital brainhealth biomarker [Slide 10]

Read More

June 25, 2021

Interview with NeuraMetrix - a digital brain health measuring biomarker

Finscreener

A brief interview with Jan Samzelius, CEO of NeuraMetrix, where he answers seven questions about NeuraMetrix.

Read More

April 14, 2021

NeuraMetrix and the Huntington Center Ulm Publish a Research Article on Monitoring Huntington Disease

Digital Health Buzz

NeuraMetrix and Huntington Center Ulm, Department of Neurology, Ulm University, Germany have jointly published a research article: “Monitoring the Phenotype in Huntington Disease by Analysis of Keyboard Typing During Real Life Computer Use” in the Journal of Huntington’s Disease.

Read More

January 27, 2021

NeuraMetrix joins with bioaccess™ to market brain health biomarker in Latin America

pharmaphorum

San Francisco’s NeuraMetrix has joined with US contract research organization (CRO) bioaccess™ to research and market a digital brain health monitoring biomarker based on typing cadence in Latin America.

Read More

July 27, 2020

Corona opens the USA for Swedish digital care incl Swedish brain digital biomarker is planning for U.S. market launch during the fall

Affärsvärlden

NeuraMetrix founder Jan Samzelius is looking forward to an exciting autumn. The company recently received approval for two medical patents in the United States, negotiates with a new industrial partner, and expects to get the go-ahead in the fall to market the product in the US from the FDA.

View Article on page 27 [Paywall] (in Swedish)
or
Read the full article in pdf format in Swedish

July 25, 2019

NeuraMetrix aims to expand Alzheimer’s typing test in Pacific region

Pharmaphorum

US medical device firm Neurametrix has struck an agreement with N-Strategy Consulting Services (NSCS) to invest in a test for neurological diseases based around typing cadence in the Asia-Pacific region...

Read More

April 15, 2019

NeuraMetrix Can Detect and Monitor Brain Diseases Through Typing Cadence

PM 360 Magazine

Doctors and scientists have long struggled to detect and monitor neurodegenerative diseases such as Alzheimer’s and Parkinson’s, but NeuraMetrix has made a breakthrough with its ability to measure brain health using a digital biomarker based on the inconsistency of typing cadence...

Read More

February 5, 2019

Now the computer can make a diagnosis

Dagens Industri

Who do you trust the most, a doctor or an algorithm? The wave of companies who challenge the traditional care industry hope that with artificial intelligence can help make a diagnosis earlier and better. Some of them include: Google, Apple and Amazon. Jan Samzelius graduated from the Stockholm School of Economics and Harvard Business School in the US and has never taken part of a medical education or worked in the pharmaceutical industry. Yet today he works with a technology which could revolutionize how diseases such as Parkinson's and Alzheimer's are detected in humans....

View Article [Paywall]
or
Read the full article in pdf format in Swedish and English

January 10, 2019

An idea gaining traction: Can measuring typing cadence help monitor and treat Parkinson’s Disease?

SharpBrains

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the NeuraMetrix digital brain health monitoring biomarker. The designation is granted for devices “that provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating human disease or conditions”...

Read More

September 01, 2018

Your Keyboard is Listening

Harvard Business School Alumni Bulletin

For his latest venture, serial entrepreneur Jan Samzelius (MBA 1979) set out to eliminate one of the biggest annoyances of the digital era: hard-to-remember passwords. But along the way, the data security expert stumbled on a tool with the potential to change how doctors diagnose and treat neurological diseases such as Parkinson’s, Huntington’s, and Alzheimer’s.

Read More

April 23, 2018

Tech Watches You for Digital Symptoms of Brain Disorders

IEEE Spectrum

Seeing an opportunity, a number of startups have devised quantitative methods to diagnose diseases or assess mental health while patients complete routine activities, like talking on a smartphone, typing on a keyboard, or scrolling through a website. Here are three companies that say they can lift the “fingerprints” of mental disorders from people’s mundane behaviors...

Read More

January 09, 2018

Jan Samzelius, CEO of Brainnovations Winner NeuraMetrix, encourages pioneers to focus on “simple, elegant solutions to big problems”

SharpBrains

Even with only a brief presentation the judges immediately got the potential impact of our technology to measure and monitor brain health and began to think about other applications for us – several we had not thought about. That was fun...

Read More

December 06, 2017

Firms Race to Find New Ways to Scan Brain Health

WebMD

How consistently you type on a keyboard and the way you use your smartphone may one day tell your doctor -- or someone else, like your employer -- if your brain is ailing...

Read More